Pages that link to "Q52026386"

The following pages link to Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. (Q52026386):

Displaying 183 items.

• Anabolic Androgenic Steroids and Aggression: Studies Using Animal Models (Q22255545) (← links)
• Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? (Q24649521) (← links)
• Pharmacology of anabolic steroids (Q24650695) (← links)
• Anabolic-androgenic steroid dependence: an emerging disorder (Q24653466) (← links)
• Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol (Q24679317) (← links)
• Muscle dysmorphia: current insights (Q26740721) (← links)
• Illicit use of androgens and other hormones: recent advances (Q26824840) (← links)
• Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis (Q27021508) (← links)
• Drug-induced gynecomastia: an evidence-based review (Q28272451) (← links)
• Psychiatric effects of anabolic steroids after burn injuries (Q28369856) (← links)
• Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis (Q30235442) (← links)
• Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors (Q30364736) (← links)
• Serum testosterone levels and symptom-based depression subtypes in men. (Q30388745) (← links)
• Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement (Q30409171) (← links)
• Corticotropin-releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse. (Q30419669) (← links)
• The anabolic-androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain (Q31900053) (← links)
• Sport psychiatry (Q33543081) (← links)
• PDE7B is involved in nandrolone decanoate hydrolysis in liver cytosol and its transcription is up-regulated by androgens in HepG2. (Q33686893) (← links)
• Steroids and steroid-like compounds (Q33690028) (← links)
• Illicit anabolic-androgenic steroid use (Q33905686) (← links)
• Membrane androgen receptors may mediate androgen reinforcement (Q33936794) (← links)
• Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm (Q33952427) (← links)
• Effects of androgenic-anabolic steroids in athletes (Q33979780) (← links)
• Diagnosis and treatment of teen drug use. (Q33992253) (← links)
• Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. (Q34017675) (← links)
• A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity (Q34033811) (← links)
• Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update (Q34063856) (← links)
• Adverse health effects of anabolic-androgenic steroids (Q34098584) (← links)
• Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women (Q34108403) (← links)
• Anabolic steroids: a review for the clinician (Q34121676) (← links)
• Anabolic steroid abuse and dependence (Q34149477) (← links)
• Multivitamin and protein supplement use is associated with positive mood states and health behaviors in US Military and Coast Guard personnel (Q34194015) (← links)
• Gym and tonic: a profile of 100 male steroid users (Q34265523) (← links)
• Direct effects of the anabolic/androgenic steroids, stanozolol and 17α-methyltestosterone, on benzodiazepine binding to the γ-aminobutyric acidA receptor (Q34299309) (← links)
• Pubertal exposure to anabolic androgenic steroids increases spine densities on neurons in the limbic system of male rats (Q34309040) (← links)
• Drug-induced mania (Q34311883) (← links)
• Eating disorders in athletes: a review of the literature (Q34363340) (← links)
• Pharmacoepidemiology of anabolic androgenic steroids: a review (Q34386281) (← links)
• Diagnosing the male steroid user: drug use, body image and disordered masculinity (Q34405973) (← links)
• Behavioural manifestations of anabolic steroid use. (Q34429602) (← links)
• Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10,365 general population men. (Q34435907) (← links)
• Anabolic steroids after total knee arthroplasty. A double blinded prospective pilot study (Q34439229) (← links)
• Sport, and use of anabolic androgenic steroids among Icelandic high school students: a critical test of three perspectives (Q34498398) (← links)
• Steroid use and long-term health risks in former athletes (Q34511060) (← links)
• The diagnostic dilemma of pathological appearance and performance enhancing drug use (Q34574338) (← links)
• Medicine and science in the fight against doping in sport (Q34595519) (← links)
• Supplements and drugs used to enhance athletic performance (Q34626441) (← links)
• Use of doping agents, particularly anabolic steroids, in sports and society (Q34783150) (← links)
• Sports doping in the adolescent athlete the hope, hype, and hyperbole (Q34893510) (← links)
• Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids (Q35028581) (← links)
• Developmental and withdrawal effects of adolescent AAS exposure on the glutamatergic system in hamsters (Q35090118) (← links)
• Dopamine activity in the lateral anterior hypothalamus modulates AAS-induced aggression through D2 but not D5 receptors (Q35090122) (← links)
• γ-Aminobutyric acid neural signaling in the lateroanterior hypothalamus modulates aggressive behavior in adolescent anabolic/androgenic steroid-treated hamsters (Q35091783) (← links)
• Development and validation of the appearance and performance enhancing drug use schedule (Q35173334) (← links)
• Steroid and nutritional supplement use in professional athletes. (Q35176225) (← links)
• Anabolic/androgenic steroid administration during adolescence and adulthood differentially modulates aggression and anxiety (Q35177530) (← links)
• Psychiatric side effects of medications prescribed in internal medicine. (Q35236318) (← links)
• Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem (Q35434335) (← links)
• Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study (Q35555918) (← links)
• Psychiatric aspects of endocrine disorders in women (Q35561534) (← links)
• Nonprescription steroids on the Internet (Q35656141) (← links)
• Current concepts in anabolic-androgenic steroids (Q35672930) (← links)
• Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. (Q35690343) (← links)
• Lasting changes in neuronal activation patterns in select forebrain regions of aggressive, adolescent anabolic/androgenic steroid-treated hamsters (Q35691420) (← links)
• Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review (Q35710533) (← links)
• Neurotoxicity by synthetic androgen steroids: oxidative stress, apoptosis, and neuropathology: A review. (Q35710568) (← links)
• Effects of anabolic androgenic steroids on the development and expression of running wheel activity and circadian rhythms in male rats (Q35766732) (← links)
• Anabolic steroid abuse among teenage girls: an illusory problem? (Q35995035) (← links)
• The role of alcohol and steroid hormones in human aggression (Q36053069) (← links)
• National Athletic Trainers' Association position statement: anabolic-androgenic steroids (Q36299949) (← links)
• Testosterone and nucleus accumbens dopamine in the male Syrian hamster (Q36509163) (← links)
• Recruitment to doping and help-seeking behavior of eight female AAS users (Q36655376) (← links)
• A conceptual model of factors contributing to the development of muscle dysmorphia (Q36680715) (← links)
• Cognitive deficits in long-term anabolic-androgenic steroid users (Q36717843) (← links)
• Serotonin modulates anxiety-like behaviors during withdrawal from adolescent anabolic-androgenic steroid exposure in Syrian hamsters (Q36729284) (← links)
• Adolescents and androgens, receptors and rewards (Q36731929) (← links)
• Androgenic anabolic steroid exposure during adolescence: ramifications for brain development and behavior (Q36788283) (← links)
• Conditional Effects of Appearance and Performance Enhancing Drugs (APEDs) Use on Mood in Powerlifters and Bodybuilders (Q36896074) (← links)
• Neuropsychiatric effects of prescription drug abuse (Q36911401) (← links)
• Anabolic-androgenic steroid dependence? Insights from animals and humans (Q36978502) (← links)
• Testosterone depletion in adult male rats increases mossy fiber transmission, LTP, and sprouting in area CA3 of hippocampus (Q37013602) (← links)
• Systemic administration of follistatin288 increases muscle mass and reduces fat accumulation in mice (Q37094346) (← links)
• Repeated anabolic/androgenic steroid exposure during adolescence alters phosphate-activated glutaminase and glutamate receptor 1 (GluR1) subunit immunoreactivity in Hamster brain: correlation with offensive aggression (Q37151269) (← links)
• Mood Symptoms in Steroid Users: The Unexamined Role of Concurrent Stimulant Use. (Q37164529) (← links)
• Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers (Q37222716) (← links)
• Testosterone levels in suicide attempters with bipolar disorder (Q37262459) (← links)
• Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease (Q37280594) (← links)
• Medical issues associated with anabolic steroid use: are they exaggerated? (Q37307083) (← links)
• The relationship between anabolic androgenic steroids and muscle dysmorphia: a review (Q37458407) (← links)
• Brain connectivity aberrations in anabolic-androgenic steroid users (Q37464926) (← links)
• Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse (Q37481427) (← links)
• Adolescent exposure to anabolic/androgenic steroids and the neurobiology of offensive aggression: a hypothalamic neural model based on findings in pubertal Syrian hamsters (Q37633050) (← links)
• Adolescent anabolic/androgenic steroids: Aggression and anxiety during exposure predict behavioral responding during withdrawal in Syrian hamsters (Mesocricetus auratus). (Q37642813) (← links)
• The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates (Q37653046) (← links)
• Muscle dysmorphia and the DSM-V conundrum: where does it belong? A review paper (Q37791514) (← links)
• Sport psychiatry: a systematic review of diagnosis and medical treatment of mental illness in athletes (Q37799811) (← links)
• Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention (Q37801534) (← links)
• Sport psychiatry and psychotherapy. Mental strains and disorders in professional sports. Challenge and answer to societal changes (Q37928951) (← links)
• Factors Influencing Clinical Correlates of Chronic Traumatic Encephalopathy (CTE): a Review. (Q38937238) (← links)
• What can allostasis tell us about anabolic-androgenic steroid addiction? (Q39288876) (← links)
• Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system. (Q39504547) (← links)
• A typological approach to testing the evolutionary functions of human female orgasm. (Q39538752) (← links)
• Current perspectives on anabolic steroids (Q40383899) (← links)
• Anabolic-androgenic steroids. Current issues. (Q40448776) (← links)
• Anabolic steroid use and associated health risk behaviours (Q41049742) (← links)
• Androgenic--anabolic steroids and body dysmorphia in young men. (Q41454592) (← links)
• Modulation of elevated plus maze behavior after chronic exposure to the anabolic steroid 17alpha-methyltestosterone in adult mice (Q42662736) (← links)
• Vasopressin differentially modulates aggression and anxiety in adolescent hamsters administered anabolic steroids (Q42732801) (← links)
• Body Image and Eating Disorders are Common among Professional and Amateur Athletes Using Performance and Image Enhancing Drugs: A Cross-Sectional Study (Q43364491) (← links)
• Combined cardiac effects of cocaine and the anabolic steroid, nandrolone, in the rat. (Q43504106) (← links)
• The testosterone metabolite and neurosteroid 3alpha-androstanediol may mediate the effects of testosterone on conditioned place preference (Q43704115) (← links)
• Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. (Q43728711) (← links)
• Lack of evidence for opioid tolerance or dependence in rhesus monkeys following high-dose anabolic-androgenic steroid administration (Q43755799) (← links)
• The anabolic androgenic steroid, nandrolone decanoate, increases the density of Fos-like immunoreactive neurons in limbic regions of guinea-pig brain (Q43904368) (← links)
• Effects of withdrawal from anabolic androgenic steroids on aggression in adult male rats (Q44025870) (← links)
• Effect of combined treatment with nandrolone and cocaine on the NMDA receptor gene expression in the rat nucleus accumbens and periaqueductal gray (Q44033234) (← links)
• Body image, disordered eating and anabolic steroid use in female bodybuilders (Q44106941) (← links)
• The nucleus accumbens as a site of action for rewarding properties of testosterone and its 5alpha-reduced metabolites (Q44176727) (← links)
• Dopaminergic effects after chronic treatment with nandrolone visualized in rat brain by positron emission tomography (Q44262068) (← links)
• The effect on opioid peptides in the rat brain, after chronic treatment with the anabolic androgenic steroid, nandrolone decanoate (Q44330743) (← links)
• Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat. (Q44334151) (← links)
• Muscle dysmorphia in Hungarian non-competitive male bodybuilders (Q44354785) (← links)
• Effects of nandrolone on acute morphine responses, tolerance and dependence in mice (Q44371402) (← links)
• Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study (Q44487811) (← links)
• Chronic administration with nandrolone decanoate induces alterations in the gene-transcript content of dopamine D(1)- and D(2)-receptors in the rat brain (Q44506333) (← links)
• Glutamic acid decarboxylase (GAD65) immunoreactivity in brains of aggressive, adolescent anabolic steroid-treated hamsters (Q44650069) (← links)
• Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents. (Q44796283) (← links)
• Anabolic-androgenic steroid use among high school football players (Q44859707) (← links)
• Frequency and nature of testicular and paratesticular lesions in forensic autopsies (Q44921427) (← links)
• Psychological and physical impact of anabolic-androgenic steroid dependence (Q45061232) (← links)
• High doses of nandrolone decanoate reduce volume of testis and length of seminiferous tubules in rats. (Q45276895) (← links)
• Anabolic-androgenic steroid does not enhance compensatory muscle hypertrophy but significantly diminish muscle damages in the rat surgical ablation model (Q46075788) (← links)
• Anabolic-androgenic steroid treatment induces behavioral disinhibition and downregulation of serotonin receptor messenger RNA in the prefrontal cortex and amygdala of male mice (Q46214634) (← links)
• Anabolic androgenic steroid affects social aggression and fear-related behaviors in male pair-housed rats (Q46476639) (← links)
• Adolescent anabolic steroid use, gender, physical activity, and other problem behaviors*. (Q46777926) (← links)
• Self-administration of estrogen and dihydrotestosterone in male hamsters (Q46865555) (← links)
• The Role of Anabolic Androgenic Steroids in Disruption of the Physiological Function in Discrete Areas of the Central Nervous System. (Q47607873) (← links)
• The use of the sociocultural attitudes towards appearance questionnaire with middle school boys and girls (Q47620076) (← links)
• Sport psychiatry and psychotherapeutic intervention, circa 2016. (Q47926290) (← links)
• White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study (Q48392013) (← links)
• Sex steroids and human behavior: implications for developmental psychopathology. (Q48410210) (← links)
• Genetic variation in the hypothalamic-pituitary-adrenocortical axis regulatory factor, T-box 19, and the angry/hostility personality trait (Q48451216) (← links)
• Use of anabolic steroids and associated health risks among gay men attending London gyms (Q48669417) (← links)
• Testosterone and suicidal behavior (Q48723437) (← links)
• Effects of an anabolic-androgenic steroid on the regulation of the NMDA receptor NR1, NR2A and NR2B subunit mRNAs in brain regions of the male rat. (Q48725984) (← links)
• Fat-Free Mass Index in NCAA Division I and II Collegiate American Football Players (Q50193380) (← links)
• Exposure to media predicts use of dietary supplements and anabolic-androgenic steroids among Flemish adolescent boys. (Q50924113) (← links)
• Subchronic nandrolone administration reduces cardiac oxidative markers during restraint stress by modulating protein expression patterns. (Q51040629) (← links)
• Psychosexual effects of three doses of testosterone cycling in normal men. (Q51091872) (← links)
• Gonadectomy enhances shock-induced behavioral inhibition in adult male rats: implications for impulsive behavior. (Q51406922) (← links)
• Factors influencing aggression toward females by male rats exposed to anabolic androgenic steroids during puberty. (Q51779828) (← links)
• Physical provocation of pubertal anabolic androgenic steroid exposed male rats elicits aggression towards females. (Q51793764) (← links)
• Body image, binge eating, and bulimia nervosa in male bodybuilders. (Q51918994) (← links)
• A psychological comparison of females with anorexia nervosa and competitive male bodybuilders: body shape ideals in the extreme. (Q52092586) (← links)
• Defining the Construct of Synthetic Androgen Intoxication: An Application of General Brain Arousal. (Q52590789) (← links)
• Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review. (Q53688645) (← links)
• Evolving ideals of male body image as seen through action toys. (Q55033070) (← links)
• Health psychology and drugs in sport (Q56115421) (← links)
• Anabolic-androgenic steroid use among 133 prisoners (Q57203644) (← links)
• Avaliação descritiva sobre o uso de esteroides anabolizantes e seu efeito sobre as variáveis bioquímicas e neuroendócrinas em indivíduos que praticam exercício resistido (Q57423582) (← links)
• Anabolic Androgenic Steroids: Searching New Molecular Biomarkers (Q59791985) (← links)
• EFFECTS OF CHRONIC TREATMENT WITH TESTOSTERONE PROPIONATE ON AGGRESSION AND HORMONAL LEVELS IN INTACT MALE MICE (Q60546921) (← links)
• Steroids, psychosis and poly-substance abuse (Q61598495) (← links)
• Neuroendocrine Whiplash: Slamming the Breaks on Anabolic-Androgenic Steroids Following Repetitive Mild Traumatic Brain Injury in Rats May Worsen Outcomes (Q64256832) (← links)
• A pilot wastewater-based epidemiology assessment of anabolic steroid use in Queensland, Australia. (Q64970416) (← links)
• Body image and steroid use in male bodybuilders (Q71793898) (← links)
• A preliminary investigation into the relationship between anabolic-androgenic steroid use and the symptoms of reverse anorexia in both current and ex-users (Q73046262) (← links)
• Chronic anabolic-androgenic steroid treatment during adolescence increases anterior hypothalamic vasopressin and aggression in intact hamsters (Q73567168) (← links)
• [43 cycles of anabolic steroid treatment studied in athletes: the uses and secondary effects] (Q73772959) (← links)
• Muscle dysmorphia. An underrecognized form of body dysmorphic disorder (Q74034437) (← links)
• Anabolic androgenic steroids and violence (Q74318915) (← links)
• Anabolic agents (Q74528431) (← links)
• Anabolic steroids and violent crime--an epidemiological study at a jail in Stockholm, Sweden (Q74802399) (← links)
• The testosterone metabolite and neurosteroid 3alpha-androstanediol may mediate the effects of testosterone on conditioned place preference (Q77354291) (← links)
• Anabolic-androgenic steroid abuse and psychopathology (Q77798548) (← links)
• Vanishing bile duct syndrome and inflammatory pseudotumor associated with a case of anabolic steroid abuse (Q81086877) (← links)
• Doping use among tertiary education students in six developed countries (Q83312021) (← links)
• Serotonin type-3 receptors differentially modulate anxiety and aggression during withdrawal from adolescent anabolic steroid exposure (Q91723918) (← links)
• Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? (Q92008457) (← links)
• Chronic high-dose testosterone treatment: impact on rat cardiac contractile biology (Q92234105) (← links)
• Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents (Q92568515) (← links)
• Structural brain characteristics of anabolic-androgenic steroid dependence in men (Q92899657) (← links)
• “Mer hjelp, mindre moralpreken”: Hva brukere av anabole-androgene steroider ønsker fra helsetjenestene (Q99551545) (← links)